Rankings
▼
Calendar
TGTX FY 2018 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TGTX
TG Therapeutics, Inc.
$5B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$152,000
-0.3% YoY
Gross Profit
$64,000
42.1% margin
Operating Income
-$174M
-114736.8% margin
Net Income
-$173M
-114132.9% margin
EPS (Diluted)
$-2.30
Cash Flow
Operating Cash Flow
-$129M
Free Cash Flow
-$129M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$84M
Total Liabilities
$60M
Stockholders' Equity
$24M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$152,000
$152,381
-0.3%
Gross Profit
$64,000
$70,026
-8.6%
Operating Income
-$174M
-$119M
-46.9%
Net Income
-$173M
-$118M
-46.4%
← Q4 2017
All Quarters
Q1 2018 →